Latest news

Here you can hear the latest goings-on and news from the Prescribing Observatory for Mental Health.

Topic 1h and 3e: Prescribing antipsychotics including high dose, combined and PRN

Due to staff shortages affecting the POMH team, please note that reporting on the prescribing antipsychotics Topic has been delayed. Timelines for other Topics are currently unaffected.

Topic 20b: Improving the quality of valproate prescribing in adult mental health services

We are now in the final week of sampling for the valproate Topic. Data collection and entry will run throughout October and November. Data can be submitted through our online data entry system, Formic, on 03 October 2022.

Topic 21a: Use of melatonin

Data analysis for the melatonin Topic continues. Reports are due to be released by the end of the year.

The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on valproate use in UK mental health services.

A paper on this topic has now been published in the Journal of Psychopharmacology: 'Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit'. A link to the paper and further publications by POMH can be found on our resources page.

Our new calendar planner for 2023 is now available. A link to this can be found on our resources page.

We are pleased to confirm that the slide-sets for Topic 19b 'Prescribing for depression in adult mental health services' have now been released and are available for POMH members to download via from the online Members' Area.

The Prescribing Observatory for Mental Health initiated a quality improvement (QI) programme on clozapine use in UK mental health services.

A paper on this topic has now been published in the Journal of Psychopharmacology: 'Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit'.

A link to the paper and further publications by POMH can be found on our resources page.

We are pleased to confirm that our re-audit report for Topic 19b 'Prescribing for depression in adult mental health services' has now been released.

The report is available to members of POMH only and can be downloaded from the online Members' Area.

In 2020, POMH conducted a service evaluation outside of our planned QI programme in response to a (rescinded) Supply Disruption Alert (SDA) on the discontinuation of the Priadel brand of lithium.

The results from this service evaluation has now been published in the BJPsych Bulletin: 'Plus ça change? Switching lithium preparations'.

A link to the paper and further publications by POMH can be found on our resources page.

Read more to receive further information regarding a career in psychiatry